Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Relapsed or Refractory Multiple Myeloma
View Full LandscapeTarget Indication
Relapsed or Refractory Multiple Myeloma
Clinical Trial
NCT05572515Last updated: 5/28/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Pain
Respiratory Syncytial Viruses
Human Immunodeficiency Virus Type 1
Heart Decompensation
Psoriasis